306 assets in B-Cell Non-Hodgkin Lymphoma

Therapeutic assets addressing B-Cell Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
rs001 B-Cell Non-Hodgkin Lymphoma	Guangdong Ruishun Biotech Co., Ltd	P1	CC (43)
sar448501 B-Cell Non-Hodgkin Lymphoma	Sanofi	P1	CC (43)
Sctb35 B-Cell Non-Hodgkin Lymphoma	Sinocelltech Ltd.	P1	CC (43)
stp938 B-Cell Non-Hodgkin Lymphoma	Step Pharma, SAS	P1/2	CC (43)
Tbi-2001 B-Cell Non-Hodgkin Lymphoma	University Health Network, Toronto	P1	CC (43)
Wztl002-1 B-Cell Non-Hodgkin Lymphoma	Malaghan Institute of Medical Research	P1	CC (43)
Xirestomig B-Cell Non-Hodgkin Lymphoma	Antengene (Hangzhou) Biologics Co., Ltd.	P1	CC (43)
yk012 B-Cell Non-Hodgkin Lymphoma	Excyte Biopharma Ltd	P1	CC (43)
ace1831 B-Cell Non-Hodgkin Lymphoma	Acepodia Biotech, Inc.	P1	CC (42)
Roflumilast B-Cell Non-Hodgkin Lymphoma	The University of Texas Health Science Center at San Antonio	P1	CC (42)
0.75x10^6 cells/kg car20.19.22 cells B-Cell Non-Hodgkin Lymphoma	Medical College of Wisconsin	P1	CC (41)
abo2203 B-Cell Non-Hodgkin Lymphoma	Ruijin Hospital	P1	CC (41)
Anti-Cd19-Car Cmv-Specific T-Lymphocytes B-Cell Non-Hodgkin Lymphoma	City of Hope Medical Center	P1	CC (41)
Anti-Cd19 Car-Nk B-Cell Non-Hodgkin Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (41)
Apg-5918 B-Cell Non-Hodgkin Lymphoma	Ascentage Pharma Group Inc.	P1	CC (41)
Autologous Baffr-Targeting Car T Cells B-Cell Non-Hodgkin Lymphoma	Mayo Clinic	P1	CC (41)
Cb Dualcar-Nk19/70 B-Cell Non-Hodgkin Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (41)
cd19car-28-zeta t cells B-Cell Non-Hodgkin Lymphoma	Baylor College of Medicine	P1	CC (41)
Duocar20.19.22-D95 B-Cell Non-Hodgkin Lymphoma	University of Kansas Medical Center	P1	CC (41)
iks03 B-Cell Non-Hodgkin Lymphoma	Iksuda Therapeutics Ltd.	P1	CC (41)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer B-Cell Non-Hodgkin Lymphoma	Mayo Clinic	P1	CC (41)
jmt601 B-Cell Non-Hodgkin Lymphoma	Shanghai JMT-Bio Inc.	P1	CC (41)
Jwcar239 B-Cell Non-Hodgkin Lymphoma	Peking University Cancer Hospital & Institute	P1	CC (41)
Magrolimab B-Cell Non-Hodgkin Lymphoma	M.D. Anderson Cancer Center	P2	CC (41)
mc-1-50 B-Cell Non-Hodgkin Lymphoma	Chongqing Precision Biotech Co., Ltd	P1	CC (41)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine B-Cell Non-Hodgkin Lymphoma	City of Hope Medical Center	P1	CC (41)
n803 B-Cell Non-Hodgkin Lymphoma	University of Utah	P1	CC (41)
PRT1419 B-Cell Non-Hodgkin Lymphoma	Prelude Therapeutics	P1	CC (41)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta B-Cell Non-Hodgkin Lymphoma	Mayo Clinic	P1	CC (41)
Rocbrutinib B-Cell Non-Hodgkin Lymphoma	Guangzhou Lupeng Pharmaceutical Company LTD.	P1	CC (41)
Ruxolitinib B-Cell Non-Hodgkin Lymphoma	Mayo Clinic	P1	CC (41)
Synkir-310 B-Cell Non-Hodgkin Lymphoma	Verismo Therapeutics	P1	CC (41)
Allogeneic Natural Killer Cells B-Cell Non-Hodgkin Lymphoma	Paolo Caimi, MD	P1	CC (40)
1928z1xx trac t cell B-Cell Non-Hodgkin Lymphoma	Memorial Sloan Kettering Cancer Center	P1	C (39)
Acnk-Sup003 Cell B-Cell Non-Hodgkin Lymphoma	Donghua Zhang	Early P1	C (39)
asp2802 B-Cell Non-Hodgkin Lymphoma	Astellas Pharma Global Development, Inc.	P1	C (39)
Avelumab B-Cell Non-Hodgkin Lymphoma	Austin Health	Early P1	C (39)
Baff-R Car-T Cells B-Cell Non-Hodgkin Lymphoma	Jiangsu Topcel-KH Pharmaceutical Co., Ltd.	P1	C (39)
Bcma Car T Cells B-Cell Non-Hodgkin Lymphoma	Shanghai Cell Therapy Group Co.,Ltd	Early P1	C (39)
Btm-3566 B-Cell Non-Hodgkin Lymphoma	Bantam Pharmaceuticals	P1	C (39)
c752 B-Cell Non-Hodgkin Lymphoma	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	P1	C (39)
cd19.20.22 car t cells B-Cell Non-Hodgkin Lymphoma	University of Maryland, Baltimore	P1	C (39)
cd19 specific chimeric antigen receptor t cell B-Cell Non-Hodgkin Lymphoma	Nationwide Children's Hospital	Early P1	C (39)
cd19-targeted non-viral pd1 site-specific integrated car-t cell B-Cell Non-Hodgkin Lymphoma	Bioray Laboratories	P1	C (39)
Clic-2201 B-Cell Non-Hodgkin Lymphoma	British Columbia Cancer Agency	P1	C (39)
ct1182 B-Cell Non-Hodgkin Lymphoma	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Early P1	C (39)
Dialuminum Tetramagnesium Carbonate Dodecahydroxide Trihydrate B-Cell Non-Hodgkin Lymphoma	Astellas Pharma Global Development, Inc.	P1	C (39)
ft819 B-Cell Non-Hodgkin Lymphoma	Fate Therapeutics	P1	C (39)
fxs0683 B-Cell Non-Hodgkin Lymphoma	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	P1	C (39)
gt801 B-Cell Non-Hodgkin Lymphoma	Grit Biotechnology	Early P1	C (39)

Showing 201 to 250 of 306 assets

PreviousPage 5 of 7Next